Pharma Product Landing Page (Copywriting + Wireframe)

SECTION 2 — Full Landing Page Production Manuscript

2.1 Navigation Bar Component

2.2 Section 1: Above-the-Fold Hero Component

Copy Manuscript:

• Primary Headline (H1): Continuous Relief From Indoor & Outdoor Allergen Triggers.
  
  
• Supporting Subheadline (H2): A single 10mg dose provides 24 hours of non-drowsy symptom control. Start breathing comfortably again, without feeling slowed down.
  
  
• Primary Call-to-Action (Teal Button Text): Find an Online Retailer
  
  
• Secondary Action Link (Text Only): View Product Ingredients
  
  

2.3 Section 2: Simplified Mechanism of Action (MoA) Component

Copy Manuscript:

• Section Header: Block Allergens at the Source, Not Just the Symptoms
  
  
• Column 1 Title: 1. The Environmental Trigger
  
  
• Column 1 Body: When airborne particles like pollen, mold, dust, or pet dander enter your respiratory pathways, your immune system releases histamine—the underlying chemical trigger responsible for standard inflammatory responses.
  
  
• Column 2 Title: 2. The Selective Blockade
  
  
• Column 2 Body: Claravest contains an advanced second-generation antihistamine that selectively binds to peripheral histamine receptors. By blocking these sites, it stops the allergic cascade before common physical symptoms can begin.
  
  
• Column 3 Title: 3. Sustained Systemic Defense
  
  
• Column 3 Body: Engineered with a specialized slow-release molecular framework, a single 10mg dose provides reliable systemic stability. It provides consistent relief for 24 hours without crossing the blood-brain barrier, preventing midday fatigue.
  
  

2.4 Section 3: Consumer Eligibility & Symptom Matrix Component

Copy Manuscript:

• Section Header: Is Claravest Right for Your Symptoms?
  
  
• Section Subheading: Compare your multi-symptom coverage against traditional first-generation over-the-counter antihistamines.
  
  
• Symptom List Labels: Sneezing & Runny Nose | Itchy, Watery Eyes | Itchy Nose or Throat | Maintains Alertness / Non-Drowsy | Dosing Frequency
  
  
• Claravest Row Callouts: Once Every 24 Hours | 100% Non-Drowsy Formula (When taken as directed)
  
  

2.5 Section 4: Important Safety Information (ISI) Block

Copy Manuscript:

• Section Title: IMPORTANT SAFETY INFORMATION (ISI)
  
  
• Indications & Usage: Claravest (10mg) is an over-the-counter medication indicated for the temporary relief of symptoms associated with upper respiratory allergies, allergic rhinitis, and environmental allergy triggers in adults and children 6 years of age and older.
  
  
• Contraindications: Do not use this product if you have a known history of hypersensitivity or allergic reactions to antihistamines or any inactive components listed within the product packaging.
  
  
• Warnings & Special Precautions:
  • Individuals presenting with severe renal impairment or underlying hepatic insufficiency must consult a licensed healthcare professional before initiating use, as a modified dosing schedule may be clinically required.
  • If you are currently pregnant, planning to become pregnant, or actively nursing, consult your physician before adding this medication to your daily self-care routine.
  • Do not exceed the recommended dose of one 10mg tablet within 24 hours. Concluding therapeutic use and seeking immediate medical assistance is advised if an unexpected systemic reaction or severe hypersensitivity event occurs.
    
    
• Common Adverse Reactions: Data derived from controlled clinical screening phases indicate that Claravest is generally well tolerated. Reported secondary events occurring at incidence rates similar to or slightly above placebo include mild headache, somnolence (less than 1%), xerostomia (dry mouth), and occasional pharyngitis.
  
  

2.6 Section 5: Regulatory Compliance Footer Component

Copy Manuscript:

• Active Ingredient Statement: Active Ingredient per Tablet: Claravest Antihistamine 10mg.
  
  
• Usage Disclaimer: Read the full drug facts label on packaging before purchasing. Use strictly as directed. If symptoms persist unchanged after 14 consecutive days of self-treatment, pause usage and schedule an evaluation with a certified primary care provider.